The human genome scientists use to scout for disease just got a major makeover

The human genome scientists use to scout for disease just got a major makeover


Andrew Brookes | Image Source | Getty Images

Scientists have been using the same human genome sequence to study genomics for more than 20 years, but on Wednesday it got a major makeover.

Researchers published a new, more inclusive collection of reference human genome sequences in a landmark development that greatly expands on that original reference sequence.

The new pangenome reference includes genome sequences of 47 people from across the globe, according to a series of peer-reviewed papers published in the journal Nature on Wednesday. The original reference human genome sequence primarily came from one person, though it includes components from a total of around 20 people.

The pangenome better reflects the global gene pool, so scientists will be able to use it to more accurately identify genetic variations related to disease. The more diverse reference map will also eventually be used to help develop more personalized care that is tailored to an individual’s DNA, according to the researchers.

A genome is the complete set of DNA instructions necessary for an organism to grow and function. Scientists rely on a reference human genome to establish a “standard” they can use to study the variations that make people unique. On average, human beings’ genomes are around 99% identical, but small differences can give scientists insights into the traits that could affect an individual’s health. 

 “With a pangenome reference, we can accelerate clinical research by improving our understanding of the link between genes and disease traits,” Wen-Wei Liao, co-first author of the paper, said in a release. 

The pangenome uses advanced computational techniques to align all the genome sequences. These techniques helped fill in gaps left by the original reference by adding more than 100 million new DNA letters, the release said.  

“The human pangenome reference will enable us to represent tens of thousands of novel genomic variants in regions of the genome that were previously inaccessible,” Liao said. 

Scientists at the Human Pangenome Reference Consortium, which is funded by part of the National Institutes of Health, conducted the research.



Source

Trump says he’s ‘strongly’ considering reclassifying pot via executive order
Health

Trump says he’s ‘strongly’ considering reclassifying pot via executive order

Bill Schmitt Jr. (C) joins cannabis reform protesters outside the White House to call on U.S. President Joe Biden “to take action on cannabis clemency before the November general election” October 24, 2022 in Washington, DC. Win Mcnamee | Getty Images Pot stocks failed to light up for a second day on Monday even after […]

Read More
Why Wall Street and Jim Cramer think Danaher stock is ‘ready to go for a romp’
Health

Why Wall Street and Jim Cramer think Danaher stock is ‘ready to go for a romp’

Danaher is finally turning the corner. CNBC’s Jim Cramer sees it. Wall Street does, too. The life sciences stock is “ready to go for a romp” after years of “nightmare” performance, Cramer said during Friday’s December Monthly Meeting for Investing Club members. Danaher — which makes tools and technologies used by pharmaceutical, biotech, and medical […]

Read More
FDA approved a 0,000 Singapore work trip during government shutdown, records show
Health

FDA approved a $250,000 Singapore work trip during government shutdown, records show

SINGAPORE — Sentosa Island boasts the luxury, five-star Ora and Michael hotels, with palm-tree-lined pools, lobbies flanked with luxury stores, and a casino that adjoins both hotels and buzzes with gamblers. The Singapore resort is also where a group of federal employees from the U.S. Food and Drug Administration were sent for a work trip […]

Read More